RFIOPEN

Cancer Prevention and Research Institute of Texas Clinical Investigator Award RFA R-27.2-CIA 2027

TX-State-Cancer Prevention and Research Institute of Texas, Austin, TX·State

60 days until submission deadline — November 18, 2026

Track TX-State-Cancer Prevention and Research Institute of Texas solicitations

Get alerted when TX-State-Cancer Prevention and Research Institute of Texas posts a new RFP, and see the pre-RFP signals months before it publishes.

Get started free

Create a free account · no credit card

Aug 05, 2026
Posted Date
Nov 18, 2026
Submission Deadline
Reported Agency
Cancer Prevention and Research Institute of Texas
Contract Term
5 years
Scope Location
Austin, Texas
Submission Address
https://gmp.cprit.texas.gov

SUMMARY

The Cancer Prevention and Research Institute of Texas (CPRIT) issues Request for Applications (RFA) R-27.2-CIA for the Clinical Investigator Award to provide protected time (33%-50% effort) for midcareer clinician-scientists in clinical cancer research, therapeutic intervention, early detection, and prevention. This award supports midcareer faculty at the Associate Professor level to augment clinical research capabilities, develop preliminary data, conduct investigator-initiated clinical trials, and mentor junior investigators. Applicants may request up to $1,500,000 in total costs for up to 5 years. Applications must be submitted via the new CPRIT Grants Management Platform (GMP) starting September 16, 2026, and due by November 18, 2026, at 5 PM central time.

EVALUATION CRITERIA

Quality of the PI, Institutional commitment, career development, and mentorship plan, Relevance of PI's career and clinical trials plan, Research Environment

REQUIRED DELIVERABLES

Clinical investigator research plan, Mentorship plan for early-stage investigators, Clinical trials involving therapeutic intervention, Early detection, Prevention, Symptom control, Or behavioral interventions

REQUIRED ATTACHMENTS

Abstract, Layperson's Summary, Specific Aims and Subaims, Timeline, Specific Aims Page, Research Plan, Vertebrate Animals/Human Subjects, Publications/References, Biographical Sketches, Current/Pending Support, Institutional/Collaborator Support, Budget Justification, Budget Tab, Personnel Level of Effort, ASO Attestation Form

60
DAYS REMAINING

You're reading this because they made it public. Your competitor read the board minutes that named this project 6–18 months ago. We read those same minutes. Next time, read them first.

Work in government? Get Civic IQ free →

Frequently asked questions

Common questions about this solicitation, answered from the record.

How do I respond to this RFI from TX-State-Cancer Prevention and Research Institute of Texas?

Review the full solicitation document for submission requirements, evaluation criteria, and deadlines. The submission deadline is November 18, 2026. The solicitation specifies required deliverables that must be addressed in your response. Be sure to include all required attachments as outlined in the solicitation. Submissions should be delivered to: https://gmp.cprit.texas.gov.

What are the evaluation criteria for this solicitation?

This solicitation includes specific evaluation criteria that will be used to score proposals. The criteria include: "Quality of the PI, Institutional commitment, career development, and mentorship plan, Relevance of PI's career and clinical trials plan, Research Environment" Vendors should carefully align their proposals with each criterion to maximize their score.

Where can I find more RFPs from TX-State-Cancer Prevention and Research Institute of Texas?

All active and historical solicitations from TX-State-Cancer Prevention and Research Institute of Texas are tracked and searchable. As a state agency, TX-State-Cancer Prevention and Research Institute of Texas regularly publishes solicitations. Visit the agency profile to see current open bids, past contracts, vendor relationships, and decision-maker contacts.

What is the contract term for this solicitation?

The anticipated contract term is 5 years. Contract terms may include renewal options.

Is this solicitation still open for submissions?

Based on the posted deadline of November 18, 2026, this solicitation appears to still be accepting submissions. Deadlines may change through amendments or addenda, so always verify the current status directly with the issuing agency before preparing your response.

What documents are required to bid on this RFI?

Requirements vary by solicitation, but common documents include a technical proposal, cost/price proposal, proof of insurance, relevant certifications, past performance references, and any forms specified in the solicitation. This solicitation specifically requires the following attachments: Abstract, Layperson's Summary, Specific Aims and Subaims, Timeline, Specific Aims Page, Research Plan, Vertebrate Animals/Human Subjects, Publications/References, Biographical Sketches, Current/Pendin. Review the full document from TX-State-Cancer Prevention and Research Institute of Texas for the complete list.

Can small businesses or minority-owned firms bid on this RFI?

Most government agencies, including TX-State-Cancer Prevention and Research Institute of Texas in TX, encourage participation from small businesses, minority-owned, women-owned, and disadvantaged business enterprises (MBE/WBE/DBE). Check the full solicitation for any small business participation goals.

What happens after the RFI submission deadline?

After the deadline, the issuing agency reviews all submissions against the stated evaluation criteria. This typically includes a compliance check, technical evaluation, cost analysis, and may involve oral presentations with shortlisted vendors.

What is the scope of this project?

This solicitation defines a specific project scope. The scope covers the following locations: Austin, Texas. Review the full solicitation for detailed scope requirements.

What are the key deliverables?

The solicitation specifies the following deliverables: Clinical investigator research plan, Mentorship plan for early-stage investigators, Clinical trials involving therapeutic intervention, Early detection, Prevention, Symptom control, Or behavioral interventions. Proposals should clearly address how each deliverable will be met.

Bring us your territory.
We'll show you what is forming.

B2G and SLED sales intelligence. Surface government procurement signals from 100,000+ state, local, and education agencies months before the RFP.

Try Civic IQ for free